Example #1: The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amount of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.
Expected output: 'entities: [{'span': 'accounting principles generally accepted', 'entity': 'Legislation/Act'}, {'span': 'United States of America', 'entity': 'Location'}]'

Example #2: The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period.
Expected output: 'entities: [{'span': 'accounting principles generally accepted', 'entity': 'Legislation/Act'}, {'span': 'United States of America', 'entity': 'Location'}]'

Example #3: The accompanying unaudited consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“ US GAAP ”) for interim financial information and with the instructions to Form 10-Q and Article 8-03 of Regulation S-X.
Expected output: 'entities: [{'span': 'generally accepted accounting principles', 'entity': 'Legislation/Act'}, {'span': 'United States of America', 'entity': 'Location'}, {'span': 'US GAAP', 'entity': 'Legislation/Act'}, {'span': 'Form 10-Q', 'entity': 'Miscellaneous'}, {'span': 'Regulation S-X', 'entity': 'Legislation/Act'}]'

Example #4: Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted.
Expected output: 'entities: [{'span': 'accounting principles generally accepted', 'entity': 'Legislation/Act'}, {'span': 'United States of America', 'entity': 'Location'}]'

Example #5: The Company ’ s financial statements are prepared using generally accepted accounting principles in the United States of America applicable to a going concern which contemplates the realization of assets and liquidation of liabilities in the normal course of business.
Expected output: 'entities: [{'span': 'generally accepted accounting principles', 'entity': 'Legislation/Act'}, {'span': 'United States of America', 'entity': 'Location'}]'

Example #6: In connection with this Annual Report of Beauty Brands Group, Inc. (the “ Company ”) on Form 10-K for the year ending December 31, 2009, as filed with the Securities and Exchange Commission on the date hereof (the “ Report ”), I, Dan Kelly, Directors and Chief Financial Officer of the Company, certify to the best of my knowledge, pursuant to 18 U.S.C. 1350, as adopted pursuant to Sec. 906 of the Sarbanes-Oxley Act of 2002, that:
Expected output: 'entities: [{'span': 'Beauty Brands Group, Inc.', 'entity': 'Business'}, {'span': 'Form 10-K', 'entity': 'Miscellaneous'}, {'span': 'Dan Kelly', 'entity': 'Person'}, {'span': 'U.S.C.', 'entity': 'Legislation/Act'}, {'span': 'Sarbanes-Oxley Act of 2002', 'entity': 'Legislation/Act'}]'

Example #7: In connection with this Annual Report of Beauty Brands Group, Inc. (the “ Company ”) on Form 10-K for the year ending December 31, 2009, as filed with the Securities and Exchange Commission on the date hereof (the “ Report ”), I, James Altucher, Chairman of the Board of Directors and President of the Company, certify to the best of my knowledge, pursuant to 18 U.S.C. 1350, as adopted pursuant to Sec. 906 of the Sarbanes-Oxley Act of 2002, that:
Expected output: 'entities: [{'span': 'Beauty Brands Group, Inc.', 'entity': 'Business'}, {'span': 'Form 10-K', 'entity': 'Miscellaneous'}, {'span': 'James Altucher', 'entity': 'Person'}, {'span': 'U.S.C.', 'entity': 'Legislation/Act'}, {'span': 'Sarbanes-Oxley Act of 2002', 'entity': 'Legislation/Act'}]'

Example #8: IPOs On October 1, 2003, the Commission filed a complaint (the “ IPO Complaint ”) against J.P. Morgan Securities Inc. (predecessor to JPMS, “ JPMSI ”) in the United States District Court for the District of Columbia (the “ D.C. District Court ”) in a civil action captioned Securities and Exchange Commission v. J.P. Morgan Securities Inc..
Expected output: 'entities: [{'span': 'IPO Complaint', 'entity': 'Miscellaneous'}, {'span': 'J.P. Morgan Securities Inc.', 'entity': 'Business'}, {'span': 'JPMS', 'entity': 'Business'}, {'span': 'JPMSI', 'entity': 'Business'}, {'span': 'United States District Court for the District of Columbia', 'entity': 'Court'}, {'span': 'D.C. District Court', 'entity': 'Court'}, {'span': 'Securities and Exchange Commission', 'entity': 'Government'}]'

Example #9: Research Analysts - JPMSI On April 28, 2003, the Commission filed a complaint (the “ JPMSI Research Analysts Complaint ”) against JPMSI in the United States District Court for the Southern District of New York (the “ New York District Court ”) in a civil action captioned Securities and Exchange Commission v. J.P. Morgan Securities Inc..
Expected output: 'entities: [{'span': 'JPMSI', 'entity': 'Business'}, {'span': 'JPMSI Research Analysts Complaint', 'entity': 'Miscellaneous'}, {'span': 'United States District Court for the Southern District of New York', 'entity': 'Court'}, {'span': 'New York District Court', 'entity': 'Court'}, {'span': 'Securities and Exchange Commission', 'entity': 'Government'}, {'span': 'J.P. Morgan Securities Inc.', 'entity': 'Business'}]'

Example #10: We, the undersigned directors of Acorda Therapeutics, Inc., hereby severally constitute and appoint Ron Cohen our true and lawful attorney with full power to him to sign for us and in our names in the capacities indicated below, this Registration Statement on Form S-8 filed herewith and any and all subsequent amendments to said registration statement, and generally to do all such things in our names and on our behalf in our capacities as directors to enable Acorda Therapeutics, Inc. to comply with the provisions of the Securities Act of 1933, as amended, and all requirements of the Securities and Exchange Commission, hereby ratifying and confirming our signatures as they may be signed by our said attorney to said registration statement and any and all amendments thereto.
Expected output: 'entities: [{'span': 'Acorda Therapeutics, Inc.', 'entity': 'Business'}, {'span': 'Ron Cohen', 'entity': 'Person'}, {'span': 'Form S-8', 'entity': 'Miscellaneous'}, {'span': 'Securities Act of 1933', 'entity': 'Legislation/Act'}, {'span': 'Securities and Exchange Commission', 'entity': 'Government'}]'

